Overview

Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes

Status:
Terminated

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

To investigate how platelets recover to normal function in subjects who have symptoms of a heart attack or unstable angina and who get a loading dose of prasugrel or clopidogrel for planned coronary angiography.

Phase:

Phase 1

Details

Lead Sponsor:

Eli Lilly and Company

Collaborator:

Daiichi Sankyo Co., Ltd.

Treatments:

Clopidogrel
Prasugrel Hydrochloride
Ticlopidine